MPM BioImpact

Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer - Orna Therapeutics WATERTOWN, Mass., March 31, 2025 – Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced the appointment o...

ICYMI: Orna Therapeutics announced the appointment of Joseph Bolen, Ph.D., as CEO! Dr. Bolen, an MPM BioImpact Entrepreneur Partner, most recently served as Orna’s Chief Scientific Officer and is the ideal leader to advance its potentially best-in-class panCAR programs into the clinic next year.

31.03.2025 13:56 — 👍 0    🔁 0    💬 0    📌 0

DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved ... March 27, 2025 22:30 ETChâtillon, France, March 27, 2025 DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance V ...

Earlier this morning, DBV Technologies announced a PIPE, of up to $306.9M led by MPM BioImpact! DBV is committed to a critical mission, developing novel treatments that can potentially transform the care of food-allergic patients.

28.03.2025 14:06 — 👍 0    🔁 0    💬 0    📌 0

Congrats to Cullinan Therapeutics, which announced that its Phase 2b trial in patients with NSCLC met its primary endpoint! Cullinan was founded by MPM BioImpact and is committed to treating a variety of cancer and autoimmune disorders with high unmet medical needs. Learn more: bit.ly/3Cu39V0

30.01.2025 17:30 — 👍 0    🔁 0    💬 0    📌 0

Congrats to the recipients of the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grant: Drs. Nika N. Danial and Karin Pelka! We are proud to support paradigm-shifting research, which may advance our understanding of cancer and transform future clinical practice.

29.01.2025 12:38 — 👍 0    🔁 0    💬 0    📌 0

We are happy to join BlueSky! Keep a look out for exciting news on our portfolio companies and our firm, as well as our insights about the biotech industry!

24.01.2025 22:35 — 👍 0    🔁 0    💬 0    📌 0